Citius Oncology, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 0.5295 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 56.00M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.